Success Story: EB1A (EB1-EA) approval in 8 days after upgrading to premium processing for a Drug Delivery Systems Expert

EB1A (EB1-EA) approval in 8 days after upgrading to premium processing for a Drug Delivery Systems Expert. (Approval Notice)


Case Summary:

On November 14th, a client of ours who was working at a university in Dallas, Texas had her petition approved.  For her case, we focused our argumentation on the client’s expertise in new drug delivery methods that modify drug release profiles.

Additionally, we defined our client’s extensive drug development record in six letters of recommendation as demonstrative of how our client’s work was significant to the field and why her continued research was suited for permanent residency.

In this case our client’s citation record was very strong, including citations in English and Chinese, which we argued in such a way that the U.S.C.I.S. recognized our client’s merit.  With a strong citation record and our proven petition methodology, the U.S.C.I.S. had no problem issuing an approval within 9 days after we upgraded the case to premium processing without issuing an RFE.